Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Die Herstellerinformationen sind derzeit nicht verfügbar.
Inhaltsangabe
Evaluating Nanomedicines: Obstacles and Advancements.- Detection of Bacterial Contamination in Nanoparticle Formulations by Agar Plate Test.- Considerations and Some Practical Solutions to Overcome Nanoparticle Interference with LAL Assays and to Avoid Endotoxin Contamination in Nanoformulations.- Elemental Analysis in Biological Matrices Using ICP-MS.- PEG Quantitation Using Reversed Phase High Performance Liquid Chromatography and Charged Aerosol Detection.- Quantitation of Surface Coating on Nanoparticles Using Thermogravimetric Analysis.- Immunoelectron Microscopy for Visualization of Nanoparticles.- Imaging of Liposomes by Transmission Electron Microscopy.- Updated Method for In Vitro Analysis of Nanoparticle Hemolytic Properties.- In Vitro Assessment of Nanoparticle Effects on Blood Coagulation.- In Vitro Analysis of Nanoparticle Effects on the Zymosan Uptake by Phagocytic Cells.- Assessing NLRP3 Inflammasome Activation by Nanoparticles.- Analysis of Complement Activation by Nanoparticles.- Methods for Analysis of Nanoparticle Immunosuppressive Properties In Vitro and In Vivo.- Analysis of Pro-Inflammatory Cytokine and Type II Interferon Induction by Nanoparticles.- Analysis of Nanoparticle Adjuvant Properties In Vivo.- In Vitro and In Vivo Methods for Analysis of Nanoparticle Potential to Induce Delayed Type Hypersensitivity Reactions.- Autophagy Monitoring Assay II: Imaging Autophagy Induction in LLC-PK1 Cells Using GFP-LC3 Protein Fusion Construct.- Improved Ultrafiltration Method to Measure Drug Release from Nanomedicines Utilizing a Stable Isotope Tracer.- Designing an In Vivo Efficacy Study of Nanomedicines for Preclinical Tumor Growth Inhibition.
Evaluating Nanomedicines: Obstacles and Advancements.- Detection of Bacterial Contamination in Nanoparticle Formulations by Agar Plate Test.- Considerations and Some Practical Solutions to Overcome Nanoparticle Interference with LAL Assays and to Avoid Endotoxin Contamination in Nanoformulations.- Elemental Analysis in Biological Matrices Using ICP-MS.- PEG Quantitation Using Reversed Phase High Performance Liquid Chromatography and Charged Aerosol Detection.- Quantitation of Surface Coating on Nanoparticles Using Thermogravimetric Analysis.- Immunoelectron Microscopy for Visualization of Nanoparticles.- Imaging of Liposomes by Transmission Electron Microscopy.- Updated Method for In Vitro Analysis of Nanoparticle Hemolytic Properties.- In Vitro Assessment of Nanoparticle Effects on Blood Coagulation.- In Vitro Analysis of Nanoparticle Effects on the Zymosan Uptake by Phagocytic Cells.- Assessing NLRP3 Inflammasome Activation by Nanoparticles.- Analysis of Complement Activation by Nanoparticles.- Methods for Analysis of Nanoparticle Immunosuppressive Properties In Vitro and In Vivo.- Analysis of Pro-Inflammatory Cytokine and Type II Interferon Induction by Nanoparticles.- Analysis of Nanoparticle Adjuvant Properties In Vivo.- In Vitro and In Vivo Methods for Analysis of Nanoparticle Potential to Induce Delayed Type Hypersensitivity Reactions.- Autophagy Monitoring Assay II: Imaging Autophagy Induction in LLC-PK1 Cells Using GFP-LC3 Protein Fusion Construct.- Improved Ultrafiltration Method to Measure Drug Release from Nanomedicines Utilizing a Stable Isotope Tracer.- Designing an In Vivo Efficacy Study of Nanomedicines for Preclinical Tumor Growth Inhibition.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
